D. S. Small

Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently

Nazar Farid, Christopher D. Payne, D. S. Small et al. · Clinical Pharmacology & Therapeutics · 2007 · 321 citations

Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease

D. S. Small, Rebecca E. Wrishko, C. Steven Ernest et al. · Journal of Clinical Pharmacy and Therapeutics · 2009 · 72 citations

Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation

M. Urooj Zafar, Carlos G. Santos‐Gallego, David Vorchheimer et al. · Journal of Thrombosis and Haemostasis · 2012 · 57 citations · Full text

Thrombosis, Platelet Function Normalization, Prasugrel Loading‐dose +10

Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly Inhibits Cytochrome P450 2B6 in Humans

Nag A. Farid, C. Payne, C. Steven Ernest et al. · The Journal of Clinical Pharmacology · 2007 · 51 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmacological Study +14

Comparison of Tear Sampling Techniques for Pharmacokinetic Analysis: Ofloxacin Concentrations in Rabbit Tears after Sampling with Schirmer Tear Strips, Capillary Tubes, or Surgical Sponges

D. S. Small, JACKIE HEVY, Diane Tang‐Liu · Journal of Ocular Pharmacology and Therapeutics · 2000 · 51 citations